413 results on '"O'Rourke, Robert A."'
Search Results
2. Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study
3. MDCT imaging in Spigelian hernia, clinical, and surgical implications
4. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes
5. The human type 2 diabetes-specific visceral adipose tissue proteome and transcriptome in obesity
6. Adipose tissue and the physiologic underpinnings of metabolic disease
7. Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
8. Elucidating nanoscale mechanical properties of diabetic human adipose tissue using atomic force microscopy
9. Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice
10. Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes
11. Matrix density regulates adipocyte phenotype.
12. Adipose METTL14‐Elicited N6‐Methyladenosine Promotes Obesity, Insulin Resistance, and NAFLD Through Suppressing β Adrenergic Signaling and Lipolysis.
13. Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium
14. Obesity and cancer: at the crossroads of cellular metabolism and proliferation
15. Reporting weight change: standardized reporting accounting for baseline weight
16. Inflammation, obesity, and the promise of immunotherapy for metabolic disease
17. Diabetes-Specific Regulation of Adipocyte Metabolism by the Adipose Tissue Extracellular Matrix
18. Prevalence of Adverse Intraoperative Events during Obesity Surgery and Their Sequelae
19. Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice
20. Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)
21. Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
22. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial
23. Lumican modulates adipocyte function in obesity-associated type 2 diabetes.
24. Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical procedures from the Longitudinal Assessment of Bariatric Surgery study
25. β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing
26. Mitral Valve Prolapse With a Late-Systolic Regurgitant Murmur May Be Associated With Significant Hemodynamic Consequences
27. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease
28. Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
29. Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
30. The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity
31. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
32. Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina
33. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
34. Functional Lumen Imaging Probe to Assess Geometric Changes in the Esophagogastric Junction Following Endolumenal Fundoplication
35. Management Strategies for Internal Hernia after Gastric Bypass
36. Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?
37. Revisional bariatric surgery for failed restrictive procedures
38. Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial
39. Transoral Endoscopic Inner Layer Esophagectomy: Management of High-Grade Dysplasia and Superficial Cancer with Organ Preservation
40. Molecular Mechanisms of Obesity and Diabetes: At the Intersection of Weight Regulation, Inflammation, and Glucose Homeostasis
41. Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging) — Developed in collaboration with the American Society of Nuclear Cardiology
42. VEGF Gene Therapy Augments Localized Angiogenesis and Promotes Anastomotic Wound Healing: A Pilot Study in a Clinically Relevant Animal Model
43. Predictors of Technical Skill Acquisition Among Resident Trainees in a Laparoscopic Skills Education Program
44. Effect of PCI on quality of life in patients with stable coronary disease
45. Incorporation of Nissen fundoplication in a rat model of duodenoesophageal reflux
46. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424
47. Gastro-gastric Fistula in the Era of Divided Roux-en-Y Gastric Bypass: Strategies for Prevention, Diagnosis, and Management
48. Optimal medical therapy with or without PCI for stable coronary disease
49. Alterations in T-Cell Subset Frequency in Peripheral Blood in Obesity
50. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.